These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 19718477

  • 1. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain.
    Brügger-Andersen T, Pönitz V, Kontny F, Staines H, Grundt H, Sagara M, Nilsen DW.
    Thromb Haemost; 2009 Sep; 102(3):555-63. PubMed ID: 19718477
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
    Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D, Tarli L, Schweiger C, Fresco C, Cecere R, Tognoni G, Mantovani A, Lipid Assessment Trial Italian Network (LATIN) Investigators.
    Circulation; 2004 Oct 19; 110(16):2349-54. PubMed ID: 15477419
    [Abstract] [Full Text] [Related]

  • 3. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GY.
    J Intern Med; 2007 Dec 19; 262(6):651-8. PubMed ID: 17986200
    [Abstract] [Full Text] [Related]

  • 4. Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome.
    Mjelva ØR, Pönitz V, Brügger-Andersen T, Grundt H, Staines H, Nilsen DW.
    Eur J Prev Cardiol; 2016 Jul 19; 23(11):1130-40. PubMed ID: 26635361
    [Abstract] [Full Text] [Related]

  • 5. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM, Aukrust P, Ueland T, Smith C, Omland T, Hartford M, Caidahl K.
    Circulation; 2009 Jun 30; 119(25):3181-8. PubMed ID: 19528340
    [Abstract] [Full Text] [Related]

  • 6. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, Sasaki T, Sagara M, Kubota I.
    Am Heart J; 2008 Jan 30; 155(1):75-81. PubMed ID: 18082493
    [Abstract] [Full Text] [Related]

  • 7. Activated factor XII type A predicts long-term mortality in patients admitted with chest pain.
    Pönitz V, Brügger-Andersen T, Pritchard D, Grundt H, Staines H, Nilsen DW, RACS Study Group.
    J Thromb Haemost; 2009 Feb 30; 7(2):277-87. PubMed ID: 19054318
    [Abstract] [Full Text] [Related]

  • 8. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.
    Kilcullen N, Viswanathan K, Das R, Morrell C, Farrin A, Barth JH, Hall AS, EMMACE-2 Investigators.
    J Am Coll Cardiol; 2007 Nov 20; 50(21):2061-7. PubMed ID: 18021874
    [Abstract] [Full Text] [Related]

  • 9. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.
    J Am Coll Cardiol; 2008 Mar 25; 51(12):1188-95. PubMed ID: 18355657
    [Abstract] [Full Text] [Related]

  • 10. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
    Bassan R, Tura BR, Maisel AS.
    Coron Artery Dis; 2009 Mar 25; 20(2):143-9. PubMed ID: 19293713
    [Abstract] [Full Text] [Related]

  • 11. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.
    Indian Heart J; 2008 Mar 25; 60(6):536-42. PubMed ID: 19276492
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B.
    J Am Coll Cardiol; 2009 Jul 21; 54(4):357-64. PubMed ID: 19608034
    [Abstract] [Full Text] [Related]

  • 13. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
    Eggers KM, Kempf T, Venge P, Wallentin L, Wollert KC, Lindahl B.
    Am Heart J; 2010 Jul 21; 160(1):88-94. PubMed ID: 20598977
    [Abstract] [Full Text] [Related]

  • 14. Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI.
    Roubille F, Samri A, Cornillet L, Sportouch-Dukhan C, Davy JM, Raczka F, Gervasoni R, Pasquie JL, Cung TT, Piot C, Macia JC, Cransac F, Leclercq F.
    Eur J Intern Med; 2010 Apr 21; 21(2):131-6. PubMed ID: 20206886
    [Abstract] [Full Text] [Related]

  • 15. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS, Kong CF, Kao MP, Struthers AD.
    Am Heart J; 2009 Jul 21; 158(1):133-40. PubMed ID: 19540403
    [Abstract] [Full Text] [Related]

  • 16. B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study.
    Brügger-Andersen T, Pönitz V, Staines H, Pritchard D, Grundt H, Nilsen DW.
    BMC Cardiovasc Disord; 2008 Nov 25; 8():34. PubMed ID: 19032759
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
    Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N, Lindahl B, Horn-Wichmann R, Brabant G, Simoons ML, Armstrong PW, Califf RM, Drexler H, Wallentin L.
    Circulation; 2007 Feb 27; 115(8):962-71. PubMed ID: 17283261
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of pentraxin 3 in patients with chronic heart failure.
    Kotooka N, Inoue T, Aoki S, Anan M, Komoda H, Node K.
    Int J Cardiol; 2008 Oct 30; 130(1):19-22. PubMed ID: 18045709
    [Abstract] [Full Text] [Related]

  • 19. Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage.
    Kume N, Mitsuoka H, Hayashida K, Tanaka M.
    J Cardiol; 2011 Jul 30; 58(1):38-45. PubMed ID: 21616640
    [Abstract] [Full Text] [Related]

  • 20. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes.
    Mega JL, Morrow DA, de Lemos JA, Mohanavelu S, Cannon CP, Sabatine MS.
    J Am Coll Cardiol; 2008 Jun 24; 51(25):2422-9. PubMed ID: 18565400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.